Parkinson's Disease Research

Share this
IMRIC Lead Researcher: 
Partner Lead Researcher: 
Dr. Andres M Luzano, Professor of Neurosurgery, Toronto Western Hospital, University of Toronto
IMRIC Location: 
IMRIC, the Hebrew University of Jerusalem
Partner Location(s): 
Toronto Western Hospital, University of Toronto, Toronto, ON

IMRIC researcher Prof. Hagai Bergman, a pioneer in the development of treatment for Parkinson's and other movement disorders, has teamed up with senior scientist Dr. Andres Luzano of Toronto Western Hospital. 

Dr.  Lozano's group is a world leader in the studies of deep brain stimulation (DBS), a procedure that involves implanting a "brain pacemaker," which sends electrical impulses to specific parts of the brain to control involuntary tremors in human patients. Prof. Bergman's IMRIC group in Jerusalem is leading the research on primate models of Parkinson's, depression, and schizophrenia, as well as advanced physiological studies of human patients undergoing DBS procedures for Parkinson's and major depression. 

This IMRIC collaboration is enabling us to explore techniques used today to treat Parkinson's, with the hope of finding ways to prevent the disease from occurring.  

Collaboration Partners

Toronto Western Hospital, University of Toronto

IMRIC has teamed up senior scientist Dr. Andres Luzano of Toronto Western Hospital with IMRIC researcher Prof. Hagai Bergman, a pioneer in the development of treatment for Parkinson's and other movement disorders. 

Related Videos

Dr. Hagai Bergman, IMRIC Researcher, Basal Ganglia Research Laboratory - 1 of 3

Your rating: None Average: 4.3 (3 votes)

Canadian Impact at Hebrew University - A Spotlight on IMRIC

No votes yet

Support Us

Join the Canadian Friends of the Hebrew University in raising $50 million to harness the incredible talent of IMRIC researchers and their Canadian counterparts.